Literature DB >> 23217618

Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.

Kelechi Chikere1, Tom Chou, Paul R Gorry, Benhur Lee.   

Abstract

HIV-1 envelope (Env) uses CD4 and a coreceptor (CCR5 and/or CXCR4) for viral entry. The efficiency of receptor/coreceptor mediated entry has important implications for HIV pathogenesis and transmission. The advent of CCR5 inhibitors in clinical use also underscores the need for quantitative and predictive tools that can guide therapeutic management. Historically, measuring the efficiency of CD4/CCR5 mediated HIV entry has relied on surrogate and relatively slow throughput assays that cannot adequately capture the full spectrum of Env phenotypes. In this review, we discuss the details of the Affinofile receptor affinity profiling system that has provided a quantitative and higher throughput method to characterize viral entry efficiency as a function of CD4 and CCR5 expression levels. We will then review how the Affinofile system has been used to reveal the distinct pathophysiological properties associated with Env entry phenotypes and discuss potential shortcomings of the current system.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23217618      PMCID: PMC3522187          DOI: 10.1016/j.virol.2012.09.043

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  61 in total

1.  Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Authors:  Chunlai Jiang; Nicholas F Parrish; Craig B Wilen; Hui Li; Yue Chen; Jeffrey W Pavlicek; Anna Berg; Xiaozhi Lu; Hongshuo Song; John C Tilton; Jennifer M Pfaff; Elizabeth A Henning; Julie M Decker; M Anthony Moody; Mark S Drinker; Robert Schutte; Stephanie Freel; Georgia D Tomaras; Rebecca Nedellec; Donald E Mosier; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms; Feng Gao
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

Authors:  Christian St-Pierre; Hiroshi Manya; Michel Ouellet; Gary F Clark; Tamao Endo; Michel J Tremblay; Sachiko Sato
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

4.  Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production.

Authors:  H Blaak; L J Ran; R Rientsma; H Schuitemaker
Journal:  Virology       Date:  2000-02-15       Impact factor: 3.616

5.  Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.

Authors:  Andre J Marozsan; Dawn M Moore; Michael A Lobritz; Erika Fraundorf; Awet Abraha; Jacqueline D Reeves; Eric J Arts
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.

Authors:  Daniel L Tuttle; Cynthia B Anders; M Janette Aquino-De Jesus; Paul P Poole; Susanna L Lamers; Daniel R Briggs; Steven M Pomeroy; Louis Alexander; Keith W C Peden; Warren A Andiman; John W Sleasman; Maureen M Goodenow
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-20       Impact factor: 2.205

7.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.

Authors:  Hector R Rangel; Jan Weber; Bikram Chakraborty; Arantxa Gutierrez; Michael L Marotta; Muneer Mirza; Patti Kiser; Miguel A Martinez; Jose A Este; Miguel E Quiñones-Mateu
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.

Authors:  Fransje A Koning; David Kwa; Brigitte Boeser-Nunnink; Jos Dekker; Jose Vingerhoed; Harry Hiemstra; Hanneke Schuitemaker
Journal:  J Infect Dis       Date:  2003-09-04       Impact factor: 5.226

10.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

View more
  15 in total

Review 1.  Exosomes and other extracellular vesicles in host-pathogen interactions.

Authors:  Jeffrey S Schorey; Yong Cheng; Prachi P Singh; Victoria L Smith
Journal:  EMBO Rep       Date:  2014-12-08       Impact factor: 8.807

2.  The Effects of Statistical Multiplicity of Infection on Virus Quantification and Infectivity Assays.

Authors:  Bhaven A Mistry; Maria R D'Orsogna; Tom Chou
Journal:  Biophys J       Date:  2018-06-19       Impact factor: 4.033

3.  Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Authors:  Julie C Williams; Sofia Appelberg; Bruce A Goldberger; Thomas W Klein; John W Sleasman; Maureen M Goodenow
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-23       Impact factor: 4.147

Review 4.  HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies.

Authors:  Paul R Gorry; Nicholas Francella; Sharon R Lewin; Ronald G Collman
Journal:  J Leukoc Biol       Date:  2013-10-24       Impact factor: 4.962

5.  Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

Authors:  Hannah M Schapiro; Mukta D Khasnis; Koree Ahn; Alexandra Karagiaridi; Stephanie Hayden; Maria E Cilento; Michael J Root
Journal:  PLoS Pathog       Date:  2022-05-18       Impact factor: 7.464

6.  A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.

Authors:  Javier Garcia-Perez; Isabelle Staropoli; Stéphane Azoulay; Jean-Thomas Heinrich; Almudena Cascajero; Philippe Colin; Hugues Lortat-Jacob; Fernando Arenzana-Seisdedos; Jose Alcami; Esther Kellenberger; Bernard Lagane
Journal:  Retrovirology       Date:  2015-06-18       Impact factor: 4.602

7.  Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.

Authors:  Kelechi Chikere; Nicholas E Webb; Tom Chou; Katharina Borm; Jasminka Sterjovski; Paul R Gorry; Benhur Lee
Journal:  Retrovirology       Date:  2014-06-23       Impact factor: 4.602

8.  Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells.

Authors:  Christina Fichter; Anupriya Aggarwal; Andrew Kam Ho Wong; Samantha McAllery; Vennila Mathivanan; Bailey Hao; Hugh MacRae; Melissa J Churchill; Paul R Gorry; Michael Roche; Lachlan R Gray; Stuart Turville
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

9.  A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.

Authors:  Michael Roche; Hamid Salimi; Renee Duncan; Brendan L Wilkinson; Kelechi Chikere; Miranda S Moore; Nicholas E Webb; Helena Zappi; Jasminka Sterjovski; Jacqueline K Flynn; Anne Ellett; Lachlan R Gray; Benhur Lee; Becky Jubb; Mike Westby; Paul A Ramsland; Sharon R Lewin; Richard J Payne; Melissa J Churchill; Paul R Gorry
Journal:  Retrovirology       Date:  2013-04-20       Impact factor: 4.602

10.  Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.

Authors:  Kieran Cashin; Martin R Jakobsen; Jasminka Sterjovski; Michael Roche; Anne Ellett; Jacqueline K Flynn; Katharina Borm; Maelenn Gouillou; Melissa J Churchill; Paul R Gorry
Journal:  Retrovirology       Date:  2013-09-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.